These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28326864)

  • 21. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.
    Sirica AE; Nathanson MH; Gores GJ; Larusso NF
    Hepatology; 2008 Dec; 48(6):2040-6. PubMed ID: 18855901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma: current concepts and insights.
    Gores GJ
    Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
    [No Abstract]   [Full Text] [Related]  

  • 23. The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.
    Gil-García B; Baladrón V
    Biol Cell; 2016 Feb; 108(2):29-40. PubMed ID: 26621221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploitation of the Notch signaling pathway as a novel target for cancer therapy.
    Wang Z; Li Y; Banerjee S; Sarkar FH
    Anticancer Res; 2008; 28(6A):3621-30. PubMed ID: 19189643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch signaling in breast cancer: From pathway analysis to therapy.
    Krishna BM; Jana S; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Cancer Lett; 2019 Oct; 461():123-131. PubMed ID: 31326555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated fibroblasts in cholangiocarcinoma.
    Vaquero J; Aoudjehane L; Fouassier L
    Curr Opin Gastroenterol; 2020 Mar; 36(2):63-69. PubMed ID: 31934895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy.
    Erice O; Merino-Azpitarte M; Arbelaiz A; Gutierrez-Larranaga M; Jimenez-Aguero R; Perugorria MJ; Bujanda L; Banales JM
    Curr Drug Targets; 2017; 18(8):932-949. PubMed ID: 26302803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesis.
    Fazio C; Ricciardiello L
    Cell Death Dis; 2016 Dec; 7(12):e2515. PubMed ID: 27929540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch signaling and new therapeutic options in liver disease.
    Morell CM; Strazzabosco M
    J Hepatol; 2014 Apr; 60(4):885-90. PubMed ID: 24308992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch signaling: an emerging therapeutic target for cancer treatment.
    Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K
    Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular aspects of cholangiocarcinoma.
    Kiguchi K
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):371-9. PubMed ID: 24420749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch signaling as a therapeutic target for acute lymphoblastic leukemia.
    Bellavia D; Palermo R; Felli MP; Screpanti I; Checquolo S
    Expert Opin Ther Targets; 2018 Apr; 22(4):331-342. PubMed ID: 29527929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review).
    Vanaroj P; Chaijaroenkul W; Na-Bangchang K
    Mol Clin Oncol; 2022 Mar; 16(3):66. PubMed ID: 35154706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic alterations in cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing.
    Isomoto H
    Digestion; 2009; 79 Suppl 1():2-8. PubMed ID: 19153483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Notch signaling for cancer therapeutic intervention.
    Shao H; Huang Q; Liu ZJ
    Adv Pharmacol; 2012; 65():191-234. PubMed ID: 22959027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathways of genetic transformation in cholangiocarcinogenesis.
    Serafini FM; Radvinsky D
    Cancer Genet; 2016 Dec; 209(12):554-558. PubMed ID: 27720541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New concept: cellular senescence in pathophysiology of cholangiocarcinoma.
    Sasaki M; Nakanuma Y
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):625-38. PubMed ID: 26680649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis.
    Just PA; Poncy A; Charawi S; Dahmani R; Traore M; Dumontet T; Drouet V; Dumont F; Gilgenkrantz H; Colnot S; Terris B; Coulouarn C; Lemaigre F; Perret C
    PLoS One; 2015; 10(12):e0145400. PubMed ID: 26689699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.
    Pastore M; Lori G; Gentilini A; Taddei ML; Di Maira G; Campani C; Recalcati S; Invernizzi P; Marra F; Raggi C
    Cells; 2020 Mar; 9(3):. PubMed ID: 32138158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.